A research team discovers that by repurposing an antirheumatic gold drug, auranofin (AUR), 'last-resort' antibiotics can be resensitized for treatment of infections caused by multidrug-resistant superbugs including bloodstream infections, pneumonia and wound infections.
from Health & Medicine News -- ScienceDaily https://www.sciencedaily.com/releases/2020/11/201105113029.htm
No comments:
Post a Comment